A Risk-Adapted Approach to Patients with Stage I Seminoma according to the Status of Rete Testis: The Fourth Spanish Germ Cell Cancer Group Study-Reference-Cited by-同舟云学术

A Risk-Adapted Approach to Patients with Stage I Seminoma according to the Status of Rete Testis: The Fourth Spanish Germ Cell Cancer Group Study

Published:2018 Issue:1 Volume:95 Page:8-12
ISSN:0030-2414
Container-title:Oncology
language:en
Short-container-title:Oncology

Author:

Aparicio Jorge,Sánchez-Muñoz Alfonso,Gumà Josep,Domenech Montserrat,Meana José A.,García-Sánchez José,Bastús Romà,Gironés Regina,González-Billalabeitia Enrique,Sagastibelza Naiara,Ochenduszko Sebastián,Sánchez Alfredo,Terrasa Josefa,Germà-Lluch Josep R.,García del Muro Xavier,

Publisher

S. Karger AG

Subject

Cancer Research,Oncology,General Medicine

Reference16 articles.

1. Kollmannsberger C, Tandstad T, Bedard PL, et al: Patterns of relapse in patients with clinical stage I testicular cancer managed with active surveillance. J Clin Oncol 2015; 33: 51–57.

2. Nichols CR, Roth B, Albers P, et al: Active surveillance is the preferred approach to clinical stage I testicular cancer. J Clin Oncol 2013; 31: 3490–3493.

3. Oldenburg J, Aparicio J, Beyer J, et al: Personalizing, not patronizing: the case for patient autonomy by unbiased presentation of management options in stage I testicular cancer. Ann Oncol 2015; 26: 833–838.

4. Warde P, Specht L, Horwich A, et al: Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis. J Clin Oncol 2002; 20: 4448–4452.

5. Chung P, Daugaard G, Tyldesley S, et al: Evaluation of a prognostic model for risk of relapse in stage I seminoma surveillance. Cancer Med 2015; 4: 155–160.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomarkers of disease recurrence in stage I testicular germ cell tumours;Nature Reviews Urology;2022-08-26

2. Testicular Tumors: General Considerations;Tumors and Tumor-Like Lesions of the Testis and Adjacent Tissues;2022-08

3. Total embedding of spermatic cord and hilar soft tissue in orchiectomy for seminoma: does the extensive sampling improve pathologic risk factors?;Virchows Archiv;2022-07-01

4. Treatment options in stage I seminoma;Oncology Research;2022

5. Cost-effectiveness Analysis of Non–risk-adapted Active Surveillance for Postorchiectomy Management of Clinical Stage I Seminoma;European Urology Focus;2021-11